Millennium Management’s Capricor Therapeutics CAPR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.73M | Sell |
173,848
-48,222
| -22% | -$479K | ﹤0.01% | 2747 |
|
2025
Q1 | $2.11M | Buy |
222,070
+106,428
| +92% | +$1.01M | ﹤0.01% | 2558 |
|
2024
Q4 | $1.6M | Buy |
115,642
+20,885
| +22% | +$288K | ﹤0.01% | 2627 |
|
2024
Q3 | $1.44M | Sell |
94,757
-384,753
| -80% | -$5.85M | ﹤0.01% | 2734 |
|
2024
Q2 | $2.29M | Buy |
479,510
+186,469
| +64% | +$889K | ﹤0.01% | 2413 |
|
2024
Q1 | $1.99M | Buy |
293,041
+272,003
| +1,293% | +$1.85M | ﹤0.01% | 2591 |
|
2023
Q4 | $103K | Sell |
21,038
-23,750
| -53% | -$116K | ﹤0.01% | 3693 |
|
2023
Q3 | $153K | Buy |
+44,788
| New | +$153K | ﹤0.01% | 3686 |
|
2023
Q1 | – | Sell |
-52,728
| Closed | -$204K | – | 4568 |
|
2022
Q4 | $204K | Buy |
52,728
+25,440
| +93% | +$98.4K | ﹤0.01% | 4093 |
|
2022
Q3 | $164K | Buy |
+27,288
| New | +$164K | ﹤0.01% | 4528 |
|
2021
Q3 | – | Sell |
-13,544
| Closed | -$69K | – | 5130 |
|
2021
Q2 | $69K | Sell |
13,544
-8,846
| -40% | -$45.1K | ﹤0.01% | 4878 |
|
2021
Q1 | $105K | Sell |
22,390
-26,967
| -55% | -$126K | ﹤0.01% | 4302 |
|
2020
Q4 | $169K | Buy |
+49,357
| New | +$169K | ﹤0.01% | 3802 |
|
2016
Q3 | – | Sell |
-1,857
| Closed | -$73K | – | 3025 |
|
2016
Q2 | $73K | Hold |
1,857
| – | – | ﹤0.01% | 2817 |
|
2016
Q1 | $47K | Hold |
1,857
| – | – | ﹤0.01% | 2914 |
|
2015
Q4 | $57K | Hold |
1,857
| – | – | ﹤0.01% | 3087 |
|
2015
Q3 | $75K | Hold |
1,857
| – | – | ﹤0.01% | 3098 |
|
2015
Q2 | $94K | Hold |
1,857
| – | – | ﹤0.01% | 2968 |
|
2015
Q1 | $160K | Buy |
+1,857
| New | +$160K | ﹤0.01% | 2861 |
|